What is ARWR's current stock price?

As of now, ARWR is trading at $57.95, with a daily change of +3.02%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ARWR Stock Analysis & IQ Rating | Arrowhead Pharmaceuticals

ARWR

Arrowhead Pharmaceuticals

$57.95

+$1.70 | +3.02%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

TopRated Yesterday at 12:18

Amazon continues to capture analyst attention as Oppenheimer maintains its Outperform recommendation, signaling strong confidence in its market position. The firm price target implies a notable upside of 25.84%, reflecti...

ARWR Stock IQ

Login to see Arrowhead Pharmaceuticals (ARWR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ARWR Target Price

Login to display

Strengths

ARWR Rewards

Earnings are forecast to grow

ARWR Rewards

Upgraded on attractively valued

ARWR Rewards

Outperform the market

Technical Indicators

ARWR Technical Indicators

Overbought

ARWR Price Performance

$40.42 (+43.37%)

$27.73 (+108.98%)

$18.61 (+211.39%)

$22.37 (+159.05%)

1year

6month

3month

1month

ARWR Risk Level

ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

ARWR Analysts Opinion

ARWR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ARWR Analysts Opinion

ARWR Analysts opinion is positive and also has improved from the past 3 months

ARWR Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

67%

50%

83%

ARWR Street Sentiment

ARWR Street Sentiment is extremely bullish and have positive views on the near-term outlook

ARWR Performance Sentiment

Sentiments overview associated with ARWR events and the stock performance.

81%

14%

Positive

Negative

46 out of 57
events present

8 out of 57
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$57.71

Resistance
Price

$36.65

Current Price Range

$57.71

Show methods +

Linked to ARWR

IQ

Close Price

Change

NVS

4.27

132.28

+2.59%

SNY

4.02

49.85

-0.20%

ARWR Latest Analysis +

HC Wainwright & Co. Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 2 2025 HC Wainwright &. Co. maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 10.17% Downside

Tue Dec 2, 2025

$57.95 | +3.02%

Momentum

Rating

ARROWHEAD LUXURY CARS CELEBRATES THE SEASON OF GIVING. GLENDALE Ariz. Dec. 2 2025 /PRNewswire/ -- Arrowhead Luxury Cars is once again celebrating the Season of Giving by partnering with the Homeless Engagement Lift Partnership (H.E.L.P.) to support homeless and displaced families in the community. Arrowhead has been collecting toys for...

Tue Dec 2, 2025

$57.95 | +3.02%

Activity

B of A Securities Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 1 2025 B of A Securities maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 10.17% Downside

Tue Dec 2, 2025

$57.95 | +3.02%

Momentum

Rating

Chardan Capital Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 1 2025 Chardan Capital maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 4.12% Downside

Mon Dec 1, 2025

$56.25 | +6.74%

Momentum

Rating

ARWR: Multiple Data Readouts Ahead in 2026. By Business UpdateMultiple Data Readouts Ahead in 2026Following the recent approval of REDEMPLO® for the treatment of patients with familial chylomicronemia syndrome (FCS) Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) is now a commercial-stage company and recently reported that the drug is available for patients only one week following approval which is ahead of schedule. While the company is focused on a successful commercial launch there are a number

Mon Dec 1, 2025

$56.25 | +6.74%

Activity

Potential

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Q4 2025 Earnings Call Transcript. Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Q4 2025 Earnings Call Transcript November 25 2025 Arrowhead Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS expectations were $0.12. Operator: Ladies and gentlemen welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today’.s recorded presentation all participants will be in a listen-only mode. After the presentation the

Wed Nov 26, 2025

$57.71 | +23.34%

Earnings

Arrowhead Pharmaceuticals GAAP EPS of -$0.01 in-line revenue of $829.45M beats by $72.01M.

Tue Nov 25, 2025

$46.79 | +5.72%

Earnings

A Look Ahead: Arrowhead Pharmas Earnings Forecast. Arrowhead Pharma (NASDAQ:) is gearing up to announce its quarterly earnings on Tuesday 2025-11-25. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Arrowhead Pharma will report an Investors in Arrowhead Pharma are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for new investors ...

Mon Nov 24, 2025

$44.26 | +9.42%

Momentum

Goldman Sachs Maintains Arrowhead Pharmaceuticals (ARWR) Neutral Recommendation. Fintel reports that on November 20 2025 Goldman Sachs maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Neutral recommendation. Analyst Price Forecast Suggests 32.59% Upside

Fri Nov 21, 2025

$40.45 | +6.20%

Potential

Rating

Noteworthy Thursday Option Activity: ARWR RBLX COF. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Arrowhead Pharmaceuticals Inc (Symbol: ARWR) where a total volume of 8414 contracts has been traded thus far today a contract volume which is representative o

Thu Nov 20, 2025

$38.09 | -2.26%

Momentum

FAQ About ARWR Stock Insights

What is ARWR current stock price?

What are ARWR stock strengths?

What is ARWR Risk Level?

What is ARWR market cap and volume?

What is ARWR current Stock IQ?

Should I buy ARWR stock right now?

Is ARWR a Strong Buy right now?

What does a 'Strong Buy' rating mean for ARWR?

What does a 'Strong Sell' rating mean for ARWR?

What factors influence ARWR's Stock IQ?

Explore our ARWR Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ARWR Stock Strategies
Effective Risk Management

FIND US ON

Receive our ARWR Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ARWR

Arrowhead Pharmaceuticals

Current Price

$57.95

+$1.70 | +3.02%

52W High

$59.27

MKT CAP

$7.87B

52W Low

$9.57

VOL

$2.86M

P/E Ratio

N/A

AVG VOL

$2.25M

RSI

73.51

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ARWR Rewards

Earnings are forecast to grow

ARWR Rewards

Upgraded on attractively valued

ARWR Rewards

Outperform the market

Technical Indicators

ARWR Technical Indicators

Overbought

Linked to ARWR

Symbol

IQ

Close

Change

NVS

4.27

132.28

+2.59%

SNY

4.02

49.85

-0.20%

ARWR Price Performance

$40.42 (+43.37%)

$27.73 (+108.98%)

$18.61 (+211.39%)

$22.37 (+159.05%)

1year

6month

3month

1month

ARWR Analysts Opinion

ARWR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ARWR Analysts Opinion

ARWR Analysts opinion is positive and also has improved from the past 3 months

ARWR Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

67%

50%

83%

ARWR Street Sentiment

ARWR Street Sentiment is extremely bullish and have positive views on the near-term outlook

ARWR Risk Level

ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

ARWR Performance Sentiment

Sentiments overview associated with ARWR events and the stock performance.

81%

14%

Positive

Negative

46 out of 57
events present

8 out of 57
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$57.71

Resistance
Price

$36.65

Current Price Range

$57.71

Show methods +

ARWR Stock IQ

Login to unlock Arrowhead Pharmaceuticals (ARWR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ARWR Latest Analysis

TopRated Yesterday at 12:18

Amazon continues to capture analyst attention as Oppenheimer maintains its Outperform recommendation, signaling strong confidence in its market position. The firm price target implies a notable upside of 25.84%, reflecti...

HC Wainwright & Co. Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 2 2025 HC Wainwright &. Co. maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 10.17% Downside

Tue Dec 2, 2025

$57.95 | +3.02%

Momentum

Rating

ARROWHEAD LUXURY CARS CELEBRATES THE SEASON OF GIVING. GLENDALE Ariz. Dec. 2 2025 /PRNewswire/ -- Arrowhead Luxury Cars is once again celebrating the Season of Giving by partnering with the Homeless Engagement Lift Partnership (H.E.L.P.) to support homeless and displaced families in the community. Arrowhead has been collecting toys for...

Tue Dec 2, 2025

$57.95 | +3.02%

Activity

B of A Securities Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 1 2025 B of A Securities maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 10.17% Downside

Tue Dec 2, 2025

$57.95 | +3.02%

Momentum

Rating

Chardan Capital Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation. Fintel reports that on December 1 2025 Chardan Capital maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Buy recommendation. Analyst Price Forecast Suggests 4.12% Downside

Mon Dec 1, 2025

$56.25 | +6.74%

Momentum

Rating

ARWR: Multiple Data Readouts Ahead in 2026. By Business UpdateMultiple Data Readouts Ahead in 2026Following the recent approval of REDEMPLO® for the treatment of patients with familial chylomicronemia syndrome (FCS) Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) is now a commercial-stage company and recently reported that the drug is available for patients only one week following approval which is ahead of schedule. While the company is focused on a successful commercial launch there are a number

Mon Dec 1, 2025

$56.25 | +6.74%

Activity

Potential

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Q4 2025 Earnings Call Transcript. Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Q4 2025 Earnings Call Transcript November 25 2025 Arrowhead Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS expectations were $0.12. Operator: Ladies and gentlemen welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today’.s recorded presentation all participants will be in a listen-only mode. After the presentation the

Wed Nov 26, 2025

$57.71 | +23.34%

Earnings

Arrowhead Pharmaceuticals GAAP EPS of -$0.01 in-line revenue of $829.45M beats by $72.01M.

Tue Nov 25, 2025

$46.79 | +5.72%

Earnings

A Look Ahead: Arrowhead Pharmas Earnings Forecast. Arrowhead Pharma (NASDAQ:) is gearing up to announce its quarterly earnings on Tuesday 2025-11-25. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Arrowhead Pharma will report an Investors in Arrowhead Pharma are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for new investors ...

Mon Nov 24, 2025

$44.26 | +9.42%

Momentum

Goldman Sachs Maintains Arrowhead Pharmaceuticals (ARWR) Neutral Recommendation. Fintel reports that on November 20 2025 Goldman Sachs maintained coverage of Arrowhead Pharmaceuticals (NasdaqGS:ARWR) with a Neutral recommendation. Analyst Price Forecast Suggests 32.59% Upside

Fri Nov 21, 2025

$40.45 | +6.20%

Potential

Rating

Noteworthy Thursday Option Activity: ARWR RBLX COF. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Arrowhead Pharmaceuticals Inc (Symbol: ARWR) where a total volume of 8414 contracts has been traded thus far today a contract volume which is representative o

Thu Nov 20, 2025

$38.09 | -2.26%

Momentum

Discover ARWR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ARWR. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ARWR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ARWR Stock trends

ARWR Stock performance

ARWR Stock analysis

ARWR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ARWR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ARWR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ARWR Stock Analysis & IQ Rating | Arrowhead Pharmaceuticals

ARWR Stock IQ

ARWR Target Price

ARWR Risk Level

ARWR Analysts Opinion

ARWR Street Sentiment

ARWR Performance Sentiment

Technical Price Levels

Explore our ARWR Stock insights

Receive our ARWR Daily Alerts

ARWR Street Sentiment

ARWR Risk Level

Technical Price Levels

Discover ARWR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ARWR. We're here to help you make informed investment decisions today.

Receive our ARWR Daily Alerts

ARWR Runner Alarm